Zacks: Analysts Expect CareMax, Inc. (NASDAQ:CMAX) to Post -$0.09 EPS

Analysts predict that CareMax, Inc. (NASDAQ:CMAX) will post earnings per share of ($0.09) for the current quarter, Zacks Investment Research reports. Two analysts have made estimates for CareMax’s earnings. The firm is scheduled to issue its next earnings results on Monday, February 21st.

On average, analysts expect that CareMax will report full-year earnings of ($0.34) per share for the current fiscal year. For the next fiscal year, analysts anticipate that the firm will post earnings of ($0.10) per share. Zacks Investment Research’s EPS averages are an average based on a survey of analysts that cover CareMax.

CareMax (NASDAQ:CMAX) last announced its quarterly earnings results on Monday, November 15th. The company reported ($0.03) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.33) by $0.30.

CMAX has been the topic of several research reports. Piper Sandler raised CareMax from a “neutral” rating to an “overweight” rating and set a $14.00 price target on the stock in a research note on Monday, September 13th. Cowen initiated coverage on CareMax in a research note on Thursday, September 9th. They set an “outperform” rating and a $14.00 price target on the stock. Zacks Investment Research lowered CareMax from a “buy” rating to a “hold” rating in a research note on Friday. Finally, Jefferies Financial Group initiated coverage on CareMax in a research note on Wednesday, October 20th. They set a “buy” rating and a $15.00 price target on the stock.

CareMax stock traded down $0.60 on Friday, reaching $6.20. The company’s stock had a trading volume of 180,728 shares, compared to its average volume of 247,569. The company has a debt-to-equity ratio of 0.22, a quick ratio of 5.68 and a current ratio of 5.70. The company’s fifty day moving average is $8.55. CareMax has a twelve month low of $6.19 and a twelve month high of $18.42.

Institutional investors have recently made changes to their positions in the business. FMR LLC bought a new position in shares of CareMax during the second quarter worth about $74,241,000. Maverick Capital Ltd. grew its holdings in shares of CareMax by 40.2% during the third quarter. Maverick Capital Ltd. now owns 4,316,238 shares of the company’s stock worth $41,695,000 after buying an additional 1,236,702 shares in the last quarter. Athyrium Capital Management LP bought a new position in shares of CareMax during the second quarter worth about $50,008,000. Perceptive Advisors LLC grew its holdings in shares of CareMax by 2.0% during the third quarter. Perceptive Advisors LLC now owns 3,385,000 shares of the company’s stock worth $32,699,000 after buying an additional 65,000 shares in the last quarter. Finally, Alyeska Investment Group L.P. bought a new position in shares of CareMax during the second quarter worth about $29,973,000. Institutional investors own 90.01% of the company’s stock.

CareMax Company Profile

CareMax Medical Group, LLC operates as a health care organization that offers medical services through physicians and health care professionals. The company offers primary care, specialty care, telemedicine, health and wellness, optometry, dental, and transportation services. CareMax Medical Group, LLC was founded in 2011 and is based in Miami, Florida.

Further Reading: What are popular green investing opportunities?

Get a free copy of the Zacks research report on CareMax (CMAX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for CareMax (NASDAQ:CMAX)

Receive News & Ratings for CareMax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CareMax and related companies with MarketBeat.com's FREE daily email newsletter.